Mark A. Klitenick

1.7k total citations
22 papers, 1.4k citations indexed

About

Mark A. Klitenick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Mark A. Klitenick has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 3 papers in Nutrition and Dietetics. Recurrent topics in Mark A. Klitenick's work include Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Receptor Mechanisms and Signaling (6 papers). Mark A. Klitenick is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Receptor Mechanisms and Signaling (6 papers). Mark A. Klitenick collaborates with scholars based in United States, Canada and Belgium. Mark A. Klitenick's co-authors include Peter W. Kalivas, L. Churchill, William I. Manton, Joel B. Kirkpatrick, Christopher J. Frederickson, David Wirtshafter, Ariel Y. Deutch, Chui‐Se Tham, Karen E. Asin and H.C. Fibiger and has published in prestigious journals such as Journal of Neuroscience, Analytical Chemistry and Brain Research.

In The Last Decade

Mark A. Klitenick

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Klitenick United States 18 1.1k 568 277 237 142 22 1.4k
E. Mogilnicka Poland 27 1.0k 0.9× 583 1.0× 267 1.0× 157 0.7× 192 1.4× 72 1.8k
Paul Q. Trombley United States 24 1.1k 1.0× 550 1.0× 279 1.0× 470 2.0× 305 2.1× 44 1.9k
Abdel‐Mouttalib Ouagazzal France 26 1.3k 1.1× 874 1.5× 277 1.0× 99 0.4× 356 2.5× 35 1.8k
Andrea Minelli Italy 24 1.3k 1.2× 792 1.4× 288 1.0× 118 0.5× 308 2.2× 39 2.0k
William O. Boggan United States 25 960 0.9× 561 1.0× 162 0.6× 174 0.7× 161 1.1× 64 1.7k
A. Groppetti Italy 26 1.4k 1.2× 678 1.2× 149 0.5× 100 0.4× 435 3.1× 54 2.0k
M. Teresa Vilaró Spain 28 1.8k 1.7× 1.5k 2.6× 314 1.1× 83 0.4× 166 1.2× 44 2.4k
J.M. Sarvey United States 18 1.2k 1.1× 704 1.2× 606 2.2× 231 1.0× 170 1.2× 24 1.7k
Max Récasens France 23 1.5k 1.4× 1.2k 2.1× 304 1.1× 136 0.6× 196 1.4× 57 2.3k
Sanders A. McDougall United States 22 1.4k 1.2× 618 1.1× 271 1.0× 69 0.3× 227 1.6× 95 1.8k

Countries citing papers authored by Mark A. Klitenick

Since Specialization
Citations

This map shows the geographic impact of Mark A. Klitenick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Klitenick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Klitenick more than expected).

Fields of papers citing papers by Mark A. Klitenick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Klitenick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Klitenick. The network helps show where Mark A. Klitenick may publish in the future.

Co-authorship network of co-authors of Mark A. Klitenick

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Klitenick. A scholar is included among the top collaborators of Mark A. Klitenick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Klitenick. Mark A. Klitenick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bell, Stanley C., Michael De Vivo, Sandra Lechner, et al.. (2001). ALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine Transporter. Molecular Pharmacology. 60(6). 1414–1420. 140 indexed citations
2.
Ravert, Hayden T., William B. Mathews, Mark A. Klitenick, Dean F. Wong, & Robert F. Dannals. (2001). Radiosynthesis of a ligand for studying the glycine transporter: [11C]ALX‐5407. Journal of Labelled Compounds and Radiopharmaceuticals. 44(3). 241–246. 4 indexed citations
3.
Johnson, Kari A., L. Churchill, Mark A. Klitenick, M. Stacy Hooks, & Peter W. Kalivas. (1996). Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 1122–1131. 59 indexed citations
4.
Klitenick, Mark A.. (1996). Effects of Chronic Haloperidol on Stress- and Stimulation-Induced Increases in Dopamine Release: Tests of the Depolarization Block Hypothesis. Neuropsychopharmacology. 15(4). 424–428. 19 indexed citations
5.
Klitenick, Mark A., Chui‐Se Tham, & Hans C. Fibiger. (1995). Cocaine and d‐amphetamine increase c‐fos expression in the rat cerebellum. Synapse. 19(1). 29–36. 24 indexed citations
6.
Napier, T. Celeste, Igor Mitrovic, L. Churchill, et al.. (1995). Substance P in the ventral pallidum: Projection from the ventral striatum, and electrophysiological and behavioral cinsequences of pallidal substance P. Neuroscience. 69(1). 59–70. 68 indexed citations
7.
Klitenick, Mark A. & David Wirtshafter. (1995). Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 327–336. 22 indexed citations
8.
Klitenick, Mark A., et al.. (1995). Receptor mechanisms mediating clozapine-inducedc-fos expression in the forebrain. Neuroscience. 65(3). 747–756. 64 indexed citations
9.
Klitenick, Mark A. & Peter W. Kalivas. (1994). Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.. Journal of Pharmacology and Experimental Therapeutics. 269(1). 437–448. 40 indexed citations
10.
Kalivas, Peter W., L. Churchill, & Mark A. Klitenick. (1993). GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience. 57(4). 1047–1060. 283 indexed citations
11.
Klitenick, Mark A., Ariel Y. Deutch, L. Churchill, & Peter W. Kalivas. (1992). Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience. 50(2). 371–386. 151 indexed citations
12.
See, R.E., et al.. (1992). Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats. Brain Research. 588(1). 177–180. 14 indexed citations
13.
Kalivas, Peter W., Caryn D. Striplin, Jeffery D. Steketee, Mark A. Klitenick, & Patricia Duffy. (1992). Cellular Mechanisms of Behavioral Sensitization to Drugs of Abusea. Annals of the New York Academy of Sciences. 654(1). 128–135. 53 indexed citations
14.
Kalivas, Peter W., et al.. (1991). Gabaergic and Enkephalinergic Regulation of Locomotion in the Ventral Pallidum: Involvement of the Mesolimbic Dopamine System. Advances in experimental medicine and biology. 295. 315–326. 7 indexed citations
15.
Wirtshafter, David & Mark A. Klitenick. (1989). Comparative studies of locomotor behavior following microinjections of muscimol into various sites in the paramedian tegmentum. Pharmacology Biochemistry and Behavior. 32(3). 625–628. 30 indexed citations
16.
Klitenick, Mark A. & David Wirtshafter. (1989). Elicitation of feeding, drinking, and gnawing following microinjections of muscimol into the median raphe nucleus of rats. Behavioral and Neural Biology. 51(3). 436–441. 25 indexed citations
17.
Wirtshafter, David, Mark A. Klitenick, & Karen E. Asin. (1988). Is dopamine involved in the hyperactivity produced by injections of muscimol into the median raphe nucleus?. Pharmacology Biochemistry and Behavior. 30(3). 577–583. 28 indexed citations
18.
Wirtshafter, David, Mark A. Klitenick, & Karen E. Asin. (1987). Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus. Pharmacology Biochemistry and Behavior. 27(1). 45–52. 36 indexed citations
19.
Kasarskis, Edward J., William I. Manton, Lynn D. Devenport, et al.. (1985). Effects of alcohol ingestion on zinc content of human and rat central nervous systems. Experimental Neurology. 90(1). 81–95. 16 indexed citations
20.
Klitenick, Mark A., C.J. Frederickson, & William I. Manton. (1983). Acid-vapor decomposition for determination of zinc in brain tissue by isotope dilution mass spectrometry. Analytical Chemistry. 55(6). 921–923. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026